Ocular Drug Delivery Technology Market is expected to reach US$ 3.24 Bn. at a CAGR of 9.12% during the forecast period of 2022-2029. Ocular drug delivery technology is used in the treatment of ophthalmic diseases such as cataracts, glaucoma, diabetic retinopathy, etc. Manufactures are emerging novel drug delivery technology which enables long-lasting effects and better penetration of therapeutic agents.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report Increasing the incidence of ocular diseases such as cataract and glaucoma globally is a major factor contributing to the growth of the global ocular drug delivery technology market. Furthermore, rising awareness about ocular diseases such as glaucoma and cataract globally, coupled with various governments and non-profit organizations providing education and support services, is expected to further drive the growth of the global drug delivery technology market over the forecast period. Also, the growing geriatric population will, in turn, create demand for ocular drug delivery technology, which is another factor contributing to the growth of the global drug delivery technology market. On the other hand, lack of eye surgeons is a major factor restraining the growth of the global drug delivery technology market over the forecast period.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Global Ocular Drug Delivery Technology Market is segmented by product, by formulation, by application and by end-user. Further by Product type is divided into Topical, Intraocular Implants, hydrogel system, Iontophoresis and ocular insert. In this segmentation of by product Topical segment is expected to have xx% market share during forecast period. Region-wise, North America dominates the global drug delivery technology market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure, availability of skilled medical personnel, and an increasing number of eye diseases in the region. Europe accounts for the second-largest revenue share contribution to the global drug delivery technology market, followed by markets in the Asia Pacific. The market in the Asia Pacific is projected to register moderately faster growth in terms of revenue over the forecast period, on account of increasing investment by key market players in developing markets and an increasing number of eye surgeries in the region. The ocular drug delivery technology market presently contains multiple companies having their products marketed. The manufacturers are emerging new innovative products and the market is growing thanks to increasing adoption and accessibilities of these products. The objective of the report is to present comprehensive analysis of global ocular drug delivery technology market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding global ocular drug delivery technology market dynamics, structure by analyzing the market segments, and project the global ocular drug delivery technology market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the global ocular drug delivery technology market make the report investor’s guide.
Ocular Drug Delivery Technology Market Scope: Inquire before buying
Global Ocular Drug Delivery Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 1.61 Bn. Forecast Period 2022 to 2029 CAGR: 9.12% Market Size in 2029: US $ 3.24 Bn. Segments Covered: by Product • Topical • Intraocular Implants o Biodegradable o Non-Biodegradable • Hydrogel Systems • Iontophoresis • Ocular Inserts o Non-Erodible o Erodible • Others (Punctal plugs, cyclodextrines) by Formulation • Solution • Suspension • Liposomes • Emulsion • Nanoparticles • Nano suspensions • Others (Niosomes, dendrimers) by End User • Hospitals • Ambulatory Surgical Centers • Ophthalmic Clinics Ocular Drug Delivery Technology Market, by Region
• North America • Europe • Asia Pacific • Middle East and Africa • South AmericaOcular Drug Delivery Technology Market Key Players
• Alimera Sciences, Inc. • Valeant Pharmaceuticals International, Inc. • Clearside Biomedical, Inc. • Taiwan Liposome Company, Ltd. • Novartis AG • Pfizer Inc. • Envisia Therapeutics, Inc. • Graybug Vision Inc. • Allergan, Plc. • Ocular Therapeutix, Inc • Eyegate Pharma • AesculaTech • Aerie Pharmaceuticals • Veena Delivery Systems • Kala Pharmaceuticals Frequently Asked Questions: 1. Which region has the largest share in Global Ocular Drug Delivery Market? Ans: Asia Pacific region holds the highest share in 2021. 2. What is the growth rate of Global Ocular Drug Delivery Market? Ans: The Global Ocular Drug Delivery Technology Market is growing at a CAGR of 9.12% during forecasting period 2022-2029. 3. What is scope of the Global Ocular Drug Delivery Market report? Ans: Global Ocular Drug Delivery Technology Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What is the study period of this market? Ans: The Global Ocular Drug Delivery Technology Market is studied from 2021 to 2029.
Global Ocular Drug Delivery Technology Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Ocular Drug Delivery Technology Market, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Ocular Drug Delivery Technology Market Analysis and Forecast 6.1. Global Ocular Drug Delivery Technology Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by End-user 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Ocular Drug Delivery Technology Market Value Share Analysis, by End-user 7.4. Global Ocular Drug Delivery Technology Market Size (US$ Bn) Forecast, by End-user 7.5. Global Ocular Drug Delivery Technology Market Analysis, by End-user 7.6. Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user 8. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Formulation Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type 8.4. Global Ocular Drug Delivery Technology Market Size (US$ Bn) Forecast, by Formulation Type 8.5. Global Ocular Drug Delivery Technology Market Analysis, by Formulation Type 8.6. Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type 9. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Ocular Drug Delivery Technology Market Value Share Analysis, by Application 9.4. Global Ocular Drug Delivery Technology Market Size (US$ Bn) Forecast, by Application 9.5. Global Ocular Drug Delivery Technology Market Analysis, by Application 9.6. Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Application 10. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Product Type 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Ocular Drug Delivery Technology Market Value Share Analysis, by Product Type 10.4. Global Ocular Drug Delivery Technology Market Size (US$ Bn) Forecast, by Product Type 10.5. Global Ocular Drug Delivery Technology Market Analysis, by Product Type 10.6. Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Product Type 11. Global Ocular Drug Delivery Technology Market Analysis, by Region 11.1. Global Ocular Drug Delivery Technology Market Value Share Analysis, by Region 11.2. Global Ocular Drug Delivery Technology Market Size (US$ Bn) Forecast, by Region 11.3. Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Region 12. North America Ocular Drug Delivery Technology Market Analysis 12.1. Key Findings 12.2. North America Ocular Drug Delivery Technology Market Overview 12.3. North America Ocular Drug Delivery Technology Market Value Share Analysis, by End-user 12.4. North America Ocular Drug Delivery Technology Market Forecast, by End-user 12.4.1. Hospitals 12.4.2. Ambulatory Surgical Centers 12.4.3. Ophthalmic Clinics 12.5. North America Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type 12.6. North America Ocular Drug Delivery Technology Market Forecast, by Formulation Type 12.6.1. Solution 12.6.2. Suspension 12.6.3. Liposomes 12.6.4. Emulsion 12.6.5. Nanoparticles 12.6.6. Nano suspensions 12.6.7. Others (Niosomes, dendrimers) 12.7. North America Ocular Drug Delivery Technology Market Value Share Analysis, by Application 12.8. North America Ocular Drug Delivery Technology Market Forecast, by Application 12.8.1. Glaucoma 12.8.2. Diabetic Retinopathy 12.8.3. Macular Degeneration 12.8.4. Cataract 12.8.5. Others 12.9. North America Ocular Drug Delivery Technology Market Value Share Analysis, by Product Type 12.10. North America Ocular Drug Delivery Technology Market Forecast, by Product Type 12.10.1. Topical 12.10.2. Intraocular Implants 12.10.2.1. Biodegradable 12.10.2.2. Non-Biodegradable 12.10.3. Hydrogel Systems 12.10.4. Iontophoresis 12.10.5. Ocular Inserts 12.10.5.1. Non-Erodible 12.10.5.2. Erodible 12.10.6. Others (Punctal plugs, cyclodextrines) 12.11. North America Ocular Drug Delivery Technology Market Value Share Analysis, by Country 12.12. North America Ocular Drug Delivery Technology Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Ocular Drug Delivery Technology Market Analysis, by Country 12.14. U.S. Ocular Drug Delivery Technology Market Forecast, by End-user 12.14.1. Hospitals 12.14.2. Ambulatory Surgical Centers 12.14.3. Ophthalmic Clinics 12.15. U.S. Ocular Drug Delivery Technology Market Forecast, by Formulation Type 12.15.1. Solution 12.15.2. Suspension 12.15.3. Liposomes 12.15.4. Emulsion 12.15.5. Nanoparticles 12.15.6. Nano suspensions 12.15.7. Others (Niosomes, dendrimers) 12.16. U.S. Ocular Drug Delivery Technology Market Forecast, by Application 12.16.1. Glaucoma 12.16.2. Diabetic Retinopathy 12.16.3. Macular Degeneration 12.16.4. Cataract 12.16.5. Others 12.17. U.S. Ocular Drug Delivery Technology Market Forecast, by Product Type 12.17.1. Topical 12.17.2. Intraocular Implants 12.17.2.1. Biodegradable 12.17.2.2. Non-Biodegradable 12.17.3. Hydrogel Systems 12.17.4. Iontophoresis 12.17.5. Ocular Inserts 12.17.5.1. Non-Erodible 12.17.5.2. Erodible 12.17.6. Others (Punctal plugs, cyclodextrines) 12.18. Canada Ocular Drug Delivery Technology Market Forecast, by End-user 12.18.1. Hospitals 12.18.2. Ambulatory Surgical Centers 12.18.3. Ophthalmic Clinics 12.19. Canada Ocular Drug Delivery Technology Market Forecast, by Formulation Type 12.19.1. Solution 12.19.2. Suspension 12.19.3. Liposomes 12.19.4. Emulsion 12.19.5. Nanoparticles 12.19.6. Nano suspensions 12.19.7. Others (Niosomes, dendrimers) 12.20. Canada Ocular Drug Delivery Technology Market Forecast, by Application 12.20.1. Glaucoma 12.20.2. Diabetic Retinopathy 12.20.3. Macular Degeneration 12.20.4. Cataract 12.20.5. Others 12.21. Canada Ocular Drug Delivery Technology Market Forecast, by Product Type 12.21.1. Topical 12.21.2. Intraocular Implants 12.21.2.1. Biodegradable 12.21.2.2. Non-Biodegradable 12.21.3. Hydrogel Systems 12.21.4. Iontophoresis 12.21.5. Ocular Inserts 12.21.5.1. Non-Erodible 12.21.5.2. Erodible 12.21.6. Others (Punctal plugs, cyclodextrines) 12.22. North America Ocular Drug Delivery Technology Market Attractiveness Analysis 12.22.1. By End-user 12.22.2. By Formulation Type 12.22.3. By Application 12.22.4. By Product Type 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Development 13. Europe Ocular Drug Delivery Technology Market Analysis 13.1. Key Findings 13.2. Europe Ocular Drug Delivery Technology Market Overview 13.3. Europe Ocular Drug Delivery Technology Market Value Share Analysis, by End-user 13.4. Europe Ocular Drug Delivery Technology Market Forecast, by End-user 13.4.1. Hospitals 13.4.2. Ambulatory Surgical Centers 13.4.3. Ophthalmic Clinics 13.5. Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type 13.6. Europe Ocular Drug Delivery Technology Market Forecast, by Formulation Type 13.6.1. Solution 13.6.2. Suspension 13.6.3. Liposomes 13.6.4. Emulsion 13.6.5. Nanoparticles 13.6.6. Nano suspensions 13.6.7. Others (Niosomes, dendrimers) 13.7. Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Application 13.8. Europe Ocular Drug Delivery Technology Market Forecast, by Application 13.8.1. Glaucoma 13.8.2. Diabetic Retinopathy 13.8.3. Macular Degeneration 13.8.4. Cataract 13.8.5. Others 13.9. Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Product Type 13.10. Europe Ocular Drug Delivery Technology Market Forecast, by Product Type 13.10.1. Topical 13.10.2. Intraocular Implants 13.10.2.1. Biodegradable 13.10.2.2. Non-Biodegradable 13.10.3. Hydrogel Systems 13.10.4. Iontophoresis 13.10.5. Ocular Inserts 13.10.5.1. Non-Erodible 13.10.5.2. Erodible 13.10.6. Others (Punctal plugs, cyclodextrines) 13.11. Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Country 13.12. Europe Ocular Drug Delivery Technology Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Ocular Drug Delivery Technology Market Analysis, by Country 13.14. Germany Ocular Drug Delivery Technology Market Forecast, by End-user 13.14.1. Hospitals 13.14.2. Ambulatory Surgical Centers 13.14.3. Ophthalmic Clinics 13.15. Germany Ocular Drug Delivery Technology Market Forecast, by Formulation Type 13.15.1. Solution 13.15.2. Suspension 13.15.3. Liposomes 13.15.4. Emulsion 13.15.5. Nanoparticles 13.15.6. Nano suspensions 13.15.7. Others (Niosomes, dendrimers) 13.16. Germany Ocular Drug Delivery Technology Market Forecast, by Application 13.16.1. Glaucoma 13.16.2. Diabetic Retinopathy 13.16.3. Macular Degeneration 13.16.4. Cataract 13.16.5. Others 13.17. Germany Ocular Drug Delivery Technology Market Forecast, by Product Type 13.17.1. Topical 13.17.2. Intraocular Implants 13.17.2.1. Biodegradable 13.17.2.2. Non-Biodegradable 13.17.3. Hydrogel Systems 13.17.4. Iontophoresis 13.17.5. Ocular Inserts 13.17.5.1. Non-Erodible 13.17.5.2. Erodible 13.17.6. Others (Punctal plugs, cyclodextrines) 13.18. U.K. Ocular Drug Delivery Technology Market Forecast, by End-user 13.18.1. Hospitals 13.18.2. Ambulatory Surgical Centers 13.18.3. Ophthalmic Clinics 13.19. U.K. Ocular Drug Delivery Technology Market Forecast, by Formulation Type 13.19.1. Solution 13.19.2. Suspension 13.19.3. Liposomes 13.19.4. Emulsion 13.19.5. Nanoparticles 13.19.6. Nano suspensions 13.19.7. Others (Niosomes, dendrimers) 13.20. U.K. Ocular Drug Delivery Technology Market Forecast, by Application 13.20.1. Glaucoma 13.20.2. Diabetic Retinopathy 13.20.3. Macular Degeneration 13.20.4. Cataract 13.20.5. Others 13.21. U.K. Ocular Drug Delivery Technology Market Forecast, by Product Type 13.21.1. Topical 13.21.2. Intraocular Implants 13.21.2.1. Biodegradable 13.21.2.2. Non-Biodegradable 13.21.3. Hydrogel Systems 13.21.4. Iontophoresis 13.21.5. Ocular Inserts 13.21.5.1. Non-Erodible 13.21.5.2. Erodible 13.21.6. Others (Punctal plugs, cyclodextrines) 13.22. France Ocular Drug Delivery Technology Market Forecast, by End-user 13.22.1. Hospitals 13.22.2. Ambulatory Surgical Centers 13.22.3. Ophthalmic Clinics 13.23. France Ocular Drug Delivery Technology Market Forecast, by Formulation Type 13.23.1. Solution 13.23.2. Suspension 13.23.3. Liposomes 13.23.4. Emulsion 13.23.5. Nanoparticles 13.23.6. Nano suspensions 13.23.7. Others (Niosomes, dendrimers) 13.24. France Ocular Drug Delivery Technology Market Forecast, by Application 13.24.1. Glaucoma 13.24.2. Diabetic Retinopathy 13.24.3. Macular Degeneration 13.24.4. Cataract 13.24.5. Others 13.25. France Ocular Drug Delivery Technology Market Forecast, by Product Type 13.25.1. Topical 13.25.2. Intraocular Implants 13.25.2.1. Biodegradable 13.25.2.2. Non-Biodegradable 13.25.3. Hydrogel Systems 13.25.4. Iontophoresis 13.25.5. Ocular Inserts 13.25.5.1. Non-Erodible 13.25.5.2. Erodible 13.25.6. Others (Punctal plugs, cyclodextrines) 13.26. Italy Ocular Drug Delivery Technology Market Forecast, by End-user 13.26.1. Hospitals 13.26.2. Ambulatory Surgical Centers 13.26.3. Ophthalmic Clinics 13.27. Italy Ocular Drug Delivery Technology Market Forecast, by Formulation Type 13.27.1. Solution 13.27.2. Suspension 13.27.3. Liposomes 13.27.4. Emulsion 13.27.5. Nanoparticles 13.27.6. Nano suspensions 13.27.7. Others (Niosomes, dendrimers) 13.28. Italy Ocular Drug Delivery Technology Market Forecast, by Application 13.28.1. Glaucoma 13.28.2. Diabetic Retinopathy 13.28.3. Macular Degeneration 13.28.4. Cataract 13.28.5. Others 13.29. Italy Ocular Drug Delivery Technology Market Forecast, by Product Type 13.29.1. Topical 13.29.2. Intraocular Implants 13.29.2.1. Biodegradable 13.29.2.2. Non-Biodegradable 13.29.3. Hydrogel Systems 13.29.4. Iontophoresis 13.29.5. Ocular Inserts 13.29.5.1. Non-Erodible 13.29.5.2. Erodible 13.29.6. Others (Punctal plugs, cyclodextrines) 13.30. Spain Ocular Drug Delivery Technology Market Forecast, by End-user 13.30.1. Hospitals 13.30.2. Ambulatory Surgical Centers 13.30.3. Ophthalmic Clinics 13.31. Spain Ocular Drug Delivery Technology Market Forecast, by Formulation Type 13.31.1. Solution 13.31.2. Suspension 13.31.3. Liposomes 13.31.4. Emulsion 13.31.5. Nanoparticles 13.31.6. Nano suspensions 13.31.7. Others (Niosomes, dendrimers) 13.32. Spain Ocular Drug Delivery Technology Market Forecast, by Application 13.32.1. Glaucoma 13.32.2. Diabetic Retinopathy 13.32.3. Macular Degeneration 13.32.4. Cataract 13.32.5. Others 13.33. Spain Ocular Drug Delivery Technology Market Forecast, by Product Type 13.33.1. Topical 13.33.2. Intraocular Implants 13.33.2.1. Biodegradable 13.33.2.2. Non-Biodegradable 13.33.3. Hydrogel Systems 13.33.4. Iontophoresis 13.33.5. Ocular Inserts 13.33.5.1. Non-Erodible 13.33.5.2. Erodible 13.33.6. Others (Punctal plugs, cyclodextrines) 13.34. Rest of Europe Ocular Drug Delivery Technology Market Forecast, by End-user 13.34.1. Hospitals 13.34.2. Ambulatory Surgical Centers 13.34.3. Ophthalmic Clinics 13.35. Rest of Europe Ocular Drug Delivery Technology Market Forecast, by Formulation Type 13.35.1. Solution 13.35.2. Suspension 13.35.3. Liposomes 13.35.4. Emulsion 13.35.5. Nanoparticles 13.35.6. Nano suspensions 13.35.7. Others (Niosomes, dendrimers) 13.36. Rest of Europe Ocular Drug Delivery Technology Market Forecast, by Application 13.36.1. Glaucoma 13.36.2. Diabetic Retinopathy 13.36.3. Macular Degeneration 13.36.4. Cataract 13.36.5. Others 13.37. Rest Of Europe Ocular Drug Delivery Technology Market Forecast, by Product Type 13.37.1. Topical 13.37.2. Intraocular Implants 13.37.2.1. Biodegradable 13.37.2.2. Non-Biodegradable 13.37.3. Hydrogel Systems 13.37.4. Iontophoresis 13.37.5. Ocular Inserts 13.37.5.1. Non-Erodible 13.37.5.2. Erodible 13.37.6. Others (Punctal plugs, cyclodextrines) 13.38. Europe Ocular Drug Delivery Technology Market Attractiveness Analysis 13.38.1. By End-user 13.38.2. By Formulation Type 13.38.3. By Application 13.38.4. By Product Type 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Development 14. Asia Pacific Ocular Drug Delivery Technology Market Analysis 14.1. Key Findings 14.2. Asia Pacific Ocular Drug Delivery Technology Market Overview 14.3. Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by End-user 14.4. Asia Pacific Ocular Drug Delivery Technology Market Forecast, by End-user 14.4.1. Hospitals 14.4.2. Ambulatory Surgical Centers 14.4.3. Ophthalmic Clinics 14.5. Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type 14.6. Asia Pacific Ocular Drug Delivery Technology Market Forecast, by Formulation Type 14.6.1. Solution 14.6.2. Suspension 14.6.3. Liposomes 14.6.4. Emulsion 14.6.5. Nanoparticles 14.6.6. Nano suspensions 14.6.7. Others (Niosomes, dendrimers) 14.7. Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Application 14.8. Asia Pacific Ocular Drug Delivery Technology Market Forecast, by Application 14.8.1. Glaucoma 14.8.2. Diabetic Retinopathy 14.8.3. Macular Degeneration 14.8.4. Cataract 14.8.5. Others 14.9. Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Product Type 14.10. Asia Pacific Ocular Drug Delivery Technology Market Forecast, by Product Type 14.10.1. Topical 14.10.2. Intraocular Implants 14.10.2.1. Biodegradable 14.10.2.2. Non-Biodegradable 14.10.3. Hydrogel Systems 14.10.4. Iontophoresis 14.10.5. Ocular Inserts 14.10.5.1. Non-Erodible 14.10.5.2. Erodible 14.10.6. Others (Punctal plugs, cyclodextrines) 14.11. Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Country 14.12. Asia Pacific Ocular Drug Delivery Technology Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Ocular Drug Delivery Technology Market Analysis, by Country 14.14. China Ocular Drug Delivery Technology Market Forecast, by End-user 14.14.1. Hospitals 14.14.2. Ambulatory Surgical Centers 14.14.3. Ophthalmic Clinics 14.15. China Ocular Drug Delivery Technology Market Forecast, by Formulation Type 14.15.1. Solution 14.15.2. Suspension 14.15.3. Liposomes 14.15.4. Emulsion 14.15.5. Nanoparticles 14.15.6. Nano suspensions 14.15.7. Others (Niosomes, dendrimers) 14.16. China Ocular Drug Delivery Technology Market Forecast, by Application 14.16.1. Glaucoma 14.16.2. Diabetic Retinopathy 14.16.3. Macular Degeneration 14.16.4. Cataract 14.16.5. Others 14.17. China Ocular Drug Delivery Technology Market Forecast, by Product Type 14.17.1. Topical 14.17.2. Intraocular Implants 14.17.2.1. Biodegradable 14.17.2.2. Non-Biodegradable 14.17.3. Hydrogel Systems 14.17.4. Iontophoresis 14.17.5. Ocular Inserts 14.17.5.1. Non-Erodible 14.17.5.2. Erodible 14.17.6. Others (Punctal plugs, cyclodextrines) 14.18. India Ocular Drug Delivery Technology Market Forecast, by End-user 14.18.1. Hospitals 14.18.2. Ambulatory Surgical Centers 14.18.3. Ophthalmic Clinics 14.19. India Ocular Drug Delivery Technology Market Forecast, by Formulation Type 14.19.1. Solution 14.19.2. Suspension 14.19.3. Liposomes 14.19.4. Emulsion 14.19.5. Nanoparticles 14.19.6. Nano suspensions 14.19.7. Others (Niosomes, dendrimers) 14.20. India Ocular Drug Delivery Technology Market Forecast, by Application 14.20.1. Glaucoma 14.20.2. Diabetic Retinopathy 14.20.3. Macular Degeneration 14.20.4. Cataract 14.20.5. Others 14.21. India Ocular Drug Delivery Technology Market Forecast, by Product Type 14.21.1. Topical 14.21.2. Intraocular Implants 14.21.2.1. Biodegradable 14.21.2.2. Non-Biodegradable 14.21.3. Hydrogel Systems 14.21.4. Iontophoresis 14.21.5. Ocular Inserts 14.21.5.1. Non-Erodible 14.21.5.2. Erodible 14.21.6. Others (Punctal plugs, cyclodextrines) 14.22. Japan Ocular Drug Delivery Technology Market Forecast, by End-user 14.22.1. Hospitals 14.22.2. Ambulatory Surgical Centers 14.22.3. Ophthalmic Clinics 14.23. Japan Ocular Drug Delivery Technology Market Forecast, by Formulation Type 14.23.1. Solution 14.23.2. Suspension 14.23.3. Liposomes 14.23.4. Emulsion 14.23.5. Nanoparticles 14.23.6. Nano suspensions 14.23.7. Others (Niosomes, dendrimers) 14.24. Japan Ocular Drug Delivery Technology Market Forecast, by Application 14.24.1. Glaucoma 14.24.2. Diabetic Retinopathy 14.24.3. Macular Degeneration 14.24.4. Cataract 14.24.5. Others 14.25. Japan Ocular Drug Delivery Technology Market Forecast, by Product Type 14.25.1. Topical 14.25.2. Intraocular Implants 14.25.2.1. Biodegradable 14.25.2.2. Non-Biodegradable 14.25.3. Hydrogel Systems 14.25.4. Iontophoresis 14.25.5. Ocular Inserts 14.25.5.1. Non-Erodible 14.25.5.2. Erodible 14.25.6. Others (Punctal plugs, cyclodextrines) 14.26. ASEAN Ocular Drug Delivery Technology Market Forecast, by End-user 14.26.1. Hospitals 14.26.2. Ambulatory Surgical Centers 14.26.3. Ophthalmic Clinics 14.27. ASEAN Ocular Drug Delivery Technology Market Forecast, by Formulation Type 14.27.1. Solution 14.27.2. Suspension 14.27.3. Liposomes 14.27.4. Emulsion 14.27.5. Nanoparticles 14.27.6. Nano suspensions 14.27.7. Others (Niosomes, dendrimers) 14.28. ASEAN Ocular Drug Delivery Technology Market Forecast, by Application 14.28.1. Glaucoma 14.28.2. Diabetic Retinopathy 14.28.3. Macular Degeneration 14.28.4. Cataract 14.28.5. Others 14.29. ASEAN Ocular Drug Delivery Technology Market Forecast, by Product Type 14.29.1. Topical 14.29.2. Intraocular Implants 14.29.2.1. Biodegradable 14.29.2.2. Non-Biodegradable 14.29.3. Hydrogel Systems 14.29.4. Iontophoresis 14.29.5. Ocular Inserts 14.29.5.1. Non-Erodible 14.29.5.2. Erodible 14.29.6. Others (Punctal plugs, cyclodextrines) 14.30. Rest of Asia Pacific Ocular Drug Delivery Technology Market Forecast, by End-user 14.30.1. Hospitals 14.30.2. Ambulatory Surgical Centers 14.30.3. Ophthalmic Clinics 14.31. Rest of Asia Pacific Ocular Drug Delivery Technology Market Forecast, by Formulation Type 14.31.1. Solution 14.31.2. Suspension 14.31.3. Liposomes 14.31.4. Emulsion 14.31.5. Nanoparticles 14.31.6. Nano suspensions 14.31.7. Others (Niosomes, dendrimers) 14.32. Rest of Asia Pacific Ocular Drug Delivery Technology Market Forecast, by Application 14.32.1. Glaucoma 14.32.2. Diabetic Retinopathy 14.32.3. Macular Degeneration 14.32.4. Cataract 14.32.5. Others 14.33. Rest of Asia Pacific Ocular Drug Delivery Technology Market Forecast, by Product Type 14.33.1. Topical 14.33.2. Intraocular Implants 14.33.2.1. Biodegradable 14.33.2.2. Non-Biodegradable 14.33.3. Hydrogel Systems 14.33.4. Iontophoresis 14.33.5. Ocular Inserts 14.33.5.1. Non-Erodible 14.33.5.2. Erodible 14.33.6. Others (Punctal plugs, cyclodextrines) 14.34. Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis 14.34.1. By End-user 14.34.2. By Formulation Type 14.34.3. By Application 14.34.4. By Product Type 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Development 15. Middle East & Africa Ocular Drug Delivery Technology Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Ocular Drug Delivery Technology Market Overview 15.3. Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by End-user 15.4. Middle East & Africa Ocular Drug Delivery Technology Market Forecast, by End-user 15.4.1. Hospitals 15.4.2. Ambulatory Surgical Centers 15.4.3. Ophthalmic Clinics 15.5. Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type 15.6. Middle East & Africa Ocular Drug Delivery Technology Market Forecast, by Formulation Type 15.6.1. Solution 15.6.2. Suspension 15.6.3. Liposomes 15.6.4. Emulsion 15.6.5. Nanoparticles 15.6.6. Nano suspensions 15.6.7. Others (Niosomes, dendrimers) 15.7. Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Application 15.8. Middle East & Africa Ocular Drug Delivery Technology Market Forecast, by Application 15.8.1. Glaucoma 15.8.2. Diabetic Retinopathy 15.8.3. Macular Degeneration 15.8.4. Cataract 15.8.5. Others 15.9. Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Product Type 15.10. Middle East & Africa Ocular Drug Delivery Technology Market Forecast, by Product Type 15.10.1. Topical 15.10.2. Intraocular Implants 15.10.2.1. Biodegradable 15.10.2.2. Non-Biodegradable 15.10.3. Hydrogel Systems 15.10.4. Iontophoresis 15.10.5. Ocular Inserts 15.10.5.1. Non-Erodible 15.10.5.2. Erodible 15.10.6. Others (Punctal plugs, cyclodextrines) 15.11. Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Country 15.12. Middle East & Africa Ocular Drug Delivery Technology Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Ocular Drug Delivery Technology Market Analysis, by Country 15.14. GCC Ocular Drug Delivery Technology Market Forecast, by End-user 15.14.1. Hospitals 15.14.2. Ambulatory Surgical Centers 15.14.3. Ophthalmic Clinics 15.15. GCC Ocular Drug Delivery Technology Market Forecast, by Formulation Type 15.15.1. Solution 15.15.2. Suspension 15.15.3. Liposomes 15.15.4. Emulsion 15.15.5. Nanoparticles 15.15.6. Nano suspensions 15.15.7. Others (Niosomes, dendrimers) 15.16. GCC Ocular Drug Delivery Technology Market Forecast, by Application 15.16.1. Glaucoma 15.16.2. Diabetic Retinopathy 15.16.3. Macular Degeneration 15.16.4. Cataract 15.16.5. Others 15.17. GCC Ocular Drug Delivery Technology Market Forecast, by Product Type 15.17.1. Topical 15.17.2. Intraocular Implants 15.17.2.1. Biodegradable 15.17.2.2. Non-Biodegradable 15.17.3. Hydrogel Systems 15.17.4. Iontophoresis 15.17.5. Ocular Inserts 15.17.5.1. Non-Erodible 15.17.5.2. Erodible 15.17.6. Others (Punctal plugs, cyclodextrines) 15.18. South Africa Ocular Drug Delivery Technology Market Forecast, by End-user 15.18.1. Hospitals 15.18.2. Ambulatory Surgical Centers 15.18.3. Ophthalmic Clinics 15.19. South Africa Ocular Drug Delivery Technology Market Forecast, by Formulation Type 15.19.1. Solution 15.19.2. Suspension 15.19.3. Liposomes 15.19.4. Emulsion 15.19.5. Nanoparticles 15.19.6. Nano suspensions 15.19.7. Others (Niosomes, dendrimers) 15.20. South Africa Ocular Drug Delivery Technology Market Forecast, by Application 15.20.1. Glaucoma 15.20.2. Diabetic Retinopathy 15.20.3. Macular Degeneration 15.20.4. Cataract 15.20.5. Others 15.21. South Africa Ocular Drug Delivery Technology Market Forecast, by Product Type 15.21.1. Topical 15.21.2. Intraocular Implants 15.21.2.1. Biodegradable 15.21.2.2. Non-Biodegradable 15.21.3. Hydrogel Systems 15.21.4. Iontophoresis 15.21.5. Ocular Inserts 15.21.5.1. Non-Erodible 15.21.5.2. Erodible 15.21.6. Others (Punctal plugs, cyclodextrines) 15.22. Rest of Middle East & Africa Ocular Drug Delivery Technology Market Forecast, by End-user 15.22.1. Hospitals 15.22.2. Ambulatory Surgical Centers 15.22.3. Ophthalmic Clinics 15.23. Rest of Middle East & Africa Ocular Drug Delivery Technology Market Forecast, by Formulation Type 15.23.1. Solution 15.23.2. Suspension 15.23.3. Liposomes 15.23.4. Emulsion 15.23.5. Nanoparticles 15.23.6. Nano suspensions 15.23.7. Others (Niosomes, dendrimers) 15.24. Rest of Middle East & Africa Ocular Drug Delivery Technology Market Forecast, by Application 15.24.1. Glaucoma 15.24.2. Diabetic Retinopathy 15.24.3. Macular Degeneration 15.24.4. Cataract 15.24.5. Others 15.25. Rest of Middle East & Africa Ocular Drug Delivery Technology Market Forecast, by Product Type 15.25.1. Topical 15.25.2. Intraocular Implants 15.25.2.1. Biodegradable 15.25.2.2. Non-Biodegradable 15.25.3. Hydrogel Systems 15.25.4. Iontophoresis 15.25.5. Ocular Inserts 15.25.5.1. Non-Erodible 15.25.5.2. Erodible 15.25.6. Others (Punctal plugs, cyclodextrines) 15.26. Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis 15.26.1. By End-user 15.26.2. By Formulation Type 15.26.3. By Application 15.26.4. By Product Type 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Development 16. South America Ocular Drug Delivery Technology Market Analysis 16.1. Key Findings 16.2. South America Ocular Drug Delivery Technology Market Overview 16.3. South America Ocular Drug Delivery Technology Market Value Share Analysis, by End-user 16.4. South America Ocular Drug Delivery Technology Market Forecast, by End-user 16.4.1. Hospitals 16.4.2. Ambulatory Surgical Centers 16.4.3. Ophthalmic Clinics 16.5. South America Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type 16.6. South America Ocular Drug Delivery Technology Market Forecast, by Formulation Type 16.6.1. Solution 16.6.2. Suspension 16.6.3. Liposomes 16.6.4. Emulsion 16.6.5. Nanoparticles 16.6.6. Nano suspensions 16.6.7. Others (Niosomes, dendrimers) 16.7. South America Ocular Drug Delivery Technology Market Value Share Analysis, by Application 16.8. South America Ocular Drug Delivery Technology Market Forecast, by Application 16.8.1. Glaucoma 16.8.2. Diabetic Retinopathy 16.8.3. Macular Degeneration 16.8.4. Cataract 16.8.5. Others 16.9. South America Ocular Drug Delivery Technology Market Value Share Analysis, by Product Type 16.10. South America Ocular Drug Delivery Technology Market Forecast, by Product Type 16.10.1. Topical 16.10.2. Intraocular Implants 16.10.2.1. Biodegradable 16.10.2.2. Non-Biodegradable 16.10.3. Hydrogel Systems 16.10.4. Iontophoresis 16.10.5. Ocular Inserts 16.10.5.1. Non-Erodible 16.10.5.2. Erodible 16.10.6. Others (Punctal plugs, cyclodextrines) 16.11. South America Ocular Drug Delivery Technology Market Value Share Analysis, by Country 16.12. South America Ocular Drug Delivery Technology Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Ocular Drug Delivery Technology Market Analysis, by Country 16.14. Brazil Ocular Drug Delivery Technology Market Forecast, by End-user 16.14.1. Hospitals 16.14.2. Ambulatory Surgical Centers 16.14.3. Ophthalmic Clinics 16.15. Brazil Ocular Drug Delivery Technology Market Forecast, by Formulation Type 16.15.1. Solution 16.15.2. Suspension 16.15.3. Liposomes 16.15.4. Emulsion 16.15.5. Nanoparticles 16.15.6. Nano suspensions 16.15.7. Others (Niosomes, dendrimers) 16.16. Brazil Ocular Drug Delivery Technology Market Forecast, by Application 16.16.1. Glaucoma 16.16.2. Diabetic Retinopathy 16.16.3. Macular Degeneration 16.16.4. Cataract 16.16.5. Others 16.17. Brazil Ocular Drug Delivery Technology Market Forecast, by Product Type 16.17.1. Topical 16.17.2. Intraocular Implants 16.17.2.1. Biodegradable 16.17.2.2. Non-Biodegradable 16.17.3. Hydrogel Systems 16.17.4. Iontophoresis 16.17.5. Ocular Inserts 16.17.5.1. Non-Erodible 16.17.5.2. Erodible 16.17.6. Others (Punctal plugs, cyclodextrines) 16.18. Mexico Ocular Drug Delivery Technology Market Forecast, by End-user 16.18.1. Hospitals 16.18.2. Ambulatory Surgical Centers 16.18.3. Ophthalmic Clinics 16.19. Mexico Ocular Drug Delivery Technology Market Forecast, by Formulation Type 16.19.1. Solution 16.19.2. Suspension 16.19.3. Liposomes 16.19.4. Emulsion 16.19.5. Nanoparticles 16.19.6. Nano suspensions 16.19.7. Others (Niosomes, dendrimers) 16.20. Mexico Ocular Drug Delivery Technology Market Forecast, by Application 16.20.1. Glaucoma 16.20.2. Diabetic Retinopathy 16.20.3. Macular Degeneration 16.20.4. Cataract 16.20.5. Others 16.21. Mexico Ocular Drug Delivery Technology Market Forecast, by Product Type 16.21.1. Topical 16.21.2. Intraocular Implants 16.21.2.1. Biodegradable 16.21.2.2. Non-Biodegradable 16.21.3. Hydrogel Systems 16.21.4. Iontophoresis 16.21.5. Ocular Inserts 16.21.5.1. Non-Erodible 16.21.5.2. Erodible 16.21.6. Others (Punctal plugs, cyclodextrines) 16.22. Rest of South America Ocular Drug Delivery Technology Market Forecast, by End-user 16.22.1. Hospitals 16.22.2. Ambulatory Surgical Centers 16.22.3. Ophthalmic Clinics 16.23. Rest of South America Ocular Drug Delivery Technology Market Forecast, by Formulation Type 16.23.1. Solution 16.23.2. Suspension 16.23.3. Liposomes 16.23.4. Emulsion 16.23.5. Nanoparticles 16.23.6. Nano suspensions 16.23.7. Others (Niosomes, dendrimers) 16.24. Rest of South America Ocular Drug Delivery Technology Market Forecast, by Application 16.24.1. Glaucoma 16.24.2. Diabetic Retinopathy 16.24.3. Macular Degeneration 16.24.4. Cataract 16.24.5. Others 16.25. Rest of South America Ocular Drug Delivery Technology Market Forecast, by Product Type 16.25.1. Topical 16.25.2. Intraocular Implants 16.25.2.1. Biodegradable 16.25.2.2. Non-Biodegradable 16.25.3. Hydrogel Systems 16.25.4. Iontophoresis 16.25.5. Ocular Inserts 16.25.5.1. Non-Erodible 16.25.5.2. Erodible 16.25.6. Others (Punctal plugs, cyclodextrines) 16.26. South America Ocular Drug Delivery Technology Market Attractiveness Analysis 16.26.1. By End-user 16.26.2. By Formulation Type 16.26.3. By Application 16.26.4. By Product Type 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Development 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Alimera Sciences, Inc. 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Company Footprint 17.3.2. Valeant Pharmaceuticals International, Inc. 17.3.3. Clearside Biomedical, Inc. 17.3.4. Taiwan Liposome Company, Ltd. 17.3.5. Novartis AG 17.3.6. Pfizer Inc. 17.3.7. Envisia Therapeutics, Inc. 17.3.8. Graybug Vision Inc. 17.3.9. Allergan, Plc. 17.3.10. Ocular Therapeutix, Inc. 17.3.11. Eyegate Pharma 17.3.12. AesculaTech 17.3.13. Aerie Pharmaceuticals 17.3.14. Veena Delivery Systems 17.3.15. Kala Pharmaceuticals 18. Primary Key Insights